Cancer Therapy News and Research

RSS

Cancer cells release biological 'drones' to assist in the fight against immune system

Cancer cells are more than a lump of cells growing out of control; they participate in active combat with the immune system for their own survival. Being able to evade the immune system is a hallmark of cancer.

9 Aug 2018

Cleveland Clinic awarded $4.7 million grant to study prevention of cancer-associated blood clots

The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $4.7 million grant to Cleveland Clinic to study the prevention of life-threatening, cancer-associated blood clots.

9 Aug 2018

Scientists develop 3D-printed implant that could deliver personalized treatment

Southwest Research Institute and The University of Texas at San Antonio are developing a 3D printed implant that, when injected in a patient's body, could deliver a personalized dose of medicine to treat infections as well as ailments such as arthritis, cancer and AIDS.

9 Aug 2018

Researchers find ways to render curcumin soluble and deliver it to infected tumors

In India and other countries in Southeast Asia, curcumin is often used as a spice in cooking, particularly chicken or fish. It is known for its therapeutic effect and as a way to kill germs present in raw meet.

7 Aug 2018

Childhood trauma associated with anxiety and depression in adults with head and neck cancer

Among individuals with head and neck cancer, those who experienced childhood trauma were more likely to have advanced cancer, to have higher alcohol consumption, and to experience symptoms of anxiety and depression.

6 Aug 2018

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

Mushrooms from the Far East area contain the natural chemical compounds, which could be used for the design of the novel drugs with highly specific anti-tumor activities and low-toxicity.

2 Aug 2018

New automation software cuts time taken for radiation therapy planning

Beating cancer is a race against time. Developing radiation therapy plans -- individualized maps that help doctors determine where to blast tumors -- can take days.

2 Aug 2018

New drug cocktails make targeted cancer therapies more efficient with less side effects

Mount Sinai researchers have discovered that certain drug cocktails help targeted therapies attack cancer more efficiently while lessening common side effects, according to a study published today in Cancer Research.

1 Aug 2018

Researchers discover various mechanisms of resistance to cancer therapy

An international research team under the co-direction of the University of Bern and the Netherlands Cancer Institute has discovered various mechanisms of resistance to cancer therapy. The findings help researchers to understand the self-repair of cancer cells after a therapy and thus help to fight resistant tumours more efficiently.

30 Jul 2018

Patients who underwent blood, marrow transplants may be at high risk of premature death

While blood and marrow transplants can save the life of a pediatric cancer patient, research out of the University of Alabama at Birmingham found that those patients may be at an increased risk of premature death even years or decades after the procedure as compared with the general population.

28 Jul 2018

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

On July 25, the radiation oncology department at Tübingen University Hospital introduced its new Elekta Unity MR-linac, a groundbreaking cancer treatment system that integrates two critical but distinct technologies in a single platform: a state-of-the-art, high field wide bore 1.5 Tesla MR imaging system and a next-generation linear accelerator.

27 Jul 2018

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.

27 Jul 2018

Scientists uncover new strategy to kill tumors without harming healthy cells

Scientists at Scripps Research have uncovered a new strategy to kill tumors, including some triple-negative breast cancers, without harming healthy cells, a discovery that could lead to more ways to treat tumors while reducing side effects.

26 Jul 2018

New protein complex may explain why patients develop resistance to novel anti-cancer drugs

A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication.

25 Jul 2018

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are located on the left side.

24 Jul 2018

Promising approach to stem cell therapy for treating Parkinson's disease

A major factor underlying Parkinson's Disease pathology is the loss of dopamine neurons in the substantia nigra, and thus current therapies often aim to restore dopamine signaling. However, these treatments are not curative.

24 Jul 2018

Study: Many patients concerned about financial impact of cancer diagnosis and treatment

As treatment for early stage breast cancer becomes less extensive and more precise, a new concern is surfacing: Cancer takes an enormous toll financially on many people.

23 Jul 2018

'Financial toxicity' of cancer treatment not adequately addressed by doctors, reveals study

In addition to facing new concerns about their health, individuals who are diagnosed with cancer often worry about the financial burdens of treatment.

23 Jul 2018

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine.

20 Jul 2018

Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers

Kite, a Gilead Company, and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors, have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.

19 Jul 2018

Cancer Therapy News and Research

Cancer cells release biological 'drones' to assist in the fight against immune system

Cleveland Clinic awarded $4.7 million grant to study prevention of cancer-associated blood clots

Scientists develop 3D-printed implant that could deliver personalized treatment

Researchers find ways to render curcumin soluble and deliver it to infected tumors

Childhood trauma associated with anxiety and depression in adults with head and neck cancer

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

New automation software cuts time taken for radiation therapy planning

New drug cocktails make targeted cancer therapies more efficient with less side effects

Researchers discover various mechanisms of resistance to cancer therapy

Patients who underwent blood, marrow transplants may be at high risk of premature death

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

Scientists uncover new strategy to kill tumors without harming healthy cells

New protein complex may explain why patients develop resistance to novel anti-cancer drugs

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Promising approach to stem cell therapy for treating Parkinson's disease

Study: Many patients concerned about financial impact of cancer diagnosis and treatment

'Financial toxicity' of cancer treatment not adequately addressed by doctors, reveals study

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News